Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Entasis Therapeutics Holdings Inc (NQ: ETTX ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Jul 8, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 2.190 (56) Ask (Size) 2.200 (64) Prev. Close 2.190 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 47,851,779 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022 October 12, 2022 Six abstracts selected for presentation, including three oral presentations From Entasis Therapeutics Holdings Inc. Via GlobeNewswire Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying July 14, 2022 US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Performance More News Read More Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. July 08, 2022 From Innoviva, Inc. Via Business Wire Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share May 23, 2022 Via Benzinga Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX June 03, 2022 From Scott+Scott Attorneys at Law LLP Via Business Wire 58 Biggest Movers From Yesterday May 24, 2022 Via Benzinga ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX May 23, 2022 From Kahn Swick & Foti, LLC Via Business Wire ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders May 23, 2022 From Halper Sadeh LLP Via Business Wire Innoviva to Acquire Entasis Therapeutics May 23, 2022 From Innoviva, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 May 06, 2022 Via Benzinga Entasis Therapeutics Hldg: Q1 Earnings Insights April 27, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 26, 2022 Via Benzinga Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today March 16, 2022 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022 March 16, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 March 08, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022 March 04, 2022 Via Benzinga Recap: Entasis Therapeutics Q4 Earnings March 03, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 02, 2022 Via Benzinga 54 Biggest Movers From Yesterday February 03, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 02, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday February 02, 2022 Via InvestorPlace 30 Stocks Moving in Friday's Pre-Market Session October 29, 2021 Via Benzinga Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion October 23, 2021 Via Talk Markets 12 Health Care Stocks Moving In Friday's Pre-Market Session October 22, 2021 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 20, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.